title: Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.
authors.forename: Heather E
authors.initials: HE
authors.lastname: Eve
authors.forename: Michelle V
authors.initials: MV
authors.lastname: Furtado
authors.forename: Michael D
authors.initials: MD
authors.lastname: Hamon
authors.forename: Simon A J
authors.initials: SA
authors.lastname: Rule
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone